Cellular transporter pharmacogenetics in metastatic colorectal cancer: Initial analysis of C80203
H. L. McLeod(University of North Carolina at Chapel Hill), Mark J. Ratain(University of Chicago), Sarita Das(KIIT University), Deanna L. Kroetz(University of California, San Francisco), Kouros Owzar(Duke University), Richard M. Goldberg(Ontario Institute for Cancer Research), KM Giacomini(University of California, San Francisco), Paula N. Friedman(University of North Carolina at Chapel Hill), F. Innocenti, Alan P. Venook(University of California, San Francisco)
Cited by 4
Related Papers
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
Hepatobiliary Cancers
|Journal of the National Comprehensive Cancer Network|2009|2.3k